Evaluating systemic thrombolysis for acute portal vein thrombosis in cirrhotic patients

FHS
May 24, 2024
5:19 pm

The prevalence of Portal Vein Thrombosis (PVT) varies significantly at different stages of liver disease: 10% in compensated patients, 17% in decompensated patients, 9% in those with acute decompensated cirrhosis, and 2-26% in post-liver transplant patients.

Canadian experts urge caution on free genetic testing and data sharing

Free genetic testing, offered partially or fully subsidized by industry, may have trade-offs, and health systems in Canada must carefully weigh potential clinical, ethical, and

July 29, 2024

Akorn’s bankruptcy, recalls bring a drug to treat lead poisoning into shortage

A drug used to treat lead poisoning is now in short supply after Akorn Pharmaceuticals filed for bankruptcy and many of its products were recalled

July 28, 2023

Surprising Link Between Weight Gain and RA Activity

In patients with rheumatoid arthritis (RA) treated with infliximab (Remicade), increases in body mass index (BMI) scores over time were not associated with increased disease

October 10, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.